1. Home
  2. AMRX vs FINV Comparison

AMRX vs FINV Comparison

Compare AMRX & FINV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • FINV
  • Stock Information
  • Founded
  • AMRX 2002
  • FINV 2007
  • Country
  • AMRX United States
  • FINV China
  • Employees
  • AMRX N/A
  • FINV N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • FINV Finance: Consumer Services
  • Sector
  • AMRX Health Care
  • FINV Finance
  • Exchange
  • AMRX Nasdaq
  • FINV Nasdaq
  • Market Cap
  • AMRX 2.3B
  • FINV 2.2B
  • IPO Year
  • AMRX N/A
  • FINV N/A
  • Fundamental
  • Price
  • AMRX $7.82
  • FINV $9.25
  • Analyst Decision
  • AMRX Strong Buy
  • FINV Strong Buy
  • Analyst Count
  • AMRX 4
  • FINV 2
  • Target Price
  • AMRX $11.50
  • FINV $11.55
  • AVG Volume (30 Days)
  • AMRX 1.6M
  • FINV 1.4M
  • Earning Date
  • AMRX 08-08-2025
  • FINV 08-19-2025
  • Dividend Yield
  • AMRX N/A
  • FINV 3.02%
  • EPS Growth
  • AMRX N/A
  • FINV 26.19
  • EPS
  • AMRX N/A
  • FINV 1.37
  • Revenue
  • AMRX $2,830,186,000.00
  • FINV $1,846,779,164.00
  • Revenue This Year
  • AMRX $9.84
  • FINV $13.72
  • Revenue Next Year
  • AMRX $7.33
  • FINV $11.25
  • P/E Ratio
  • AMRX N/A
  • FINV $6.93
  • Revenue Growth
  • AMRX 13.42
  • FINV 5.40
  • 52 Week Low
  • AMRX $6.29
  • FINV $4.63
  • 52 Week High
  • AMRX $9.48
  • FINV $11.08
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 54.91
  • FINV 60.57
  • Support Level
  • AMRX $7.72
  • FINV $8.88
  • Resistance Level
  • AMRX $8.11
  • FINV $8.99
  • Average True Range (ATR)
  • AMRX 0.26
  • FINV 0.27
  • MACD
  • AMRX 0.05
  • FINV 0.07
  • Stochastic Oscillator
  • AMRX 72.12
  • FINV 66.22

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About FINV FinVolution Group

FinVolution Group is a provider of online consumer finance in China. The company offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC, and its revenues are derived from within the PRC.

Share on Social Networks: